In this issue:
Adverse prognosis of silent vs documented MI
Common prescribing cascade in older patients with hypertension
Underrepresentation of women and older patients in lipid-lowering therapy trials
Troponin measurements, MI diagnosis and outcomes
Monotherapy with a P2Y12 inhibitor vs aspirin for secondary prevention
Long-term outcomes after total vs non-total arterial revascularisation
Rivaroxaban vs warfarin in patients with nonvalvular AF and CKD
Impact of oral anticoagulation in AF patients at very low thromboembolic risk
Worldwide prevalence of familial hypercholesterolaemia
Please login below to download this issue (PDF)